The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis

The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis

Abstract The SEPT9 gene methylation assay is the first FDA-approved blood assay for colorectal cancer (CRC) screening. Fecal immunochemical test (FIT), FIT-DNA test and CEA assay are also in vitro diagnostic (IVD) tests used in CRC screening. This meta-analysis aims to review the SEPT9 assay perform...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lele Song, Jia Jia, Xiumei Peng, Wenhua Xiao, Yuemin Li
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/85bc8435fe9c4196991cda2e5dc58d96
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares